Not applicableStudy completedNCT05286632What this trial is testingKidneYou - Innovative Digital TherapyWho this might be right forChronic Kidney DiseasesDiabetesArterial Hypertension+10 more Advice Pharma Group srl 210
Not applicableLooking for participantsNCT05434325What this trial is testingTESTING -ON Post-Trial ObservatioNal Cohort StudyWho this might be right forIgA NephropathyESRDGlomerulonephritis+1 more The George Institute 366
Testing effectiveness (Phase 2)WithdrawnNCT05599815What this trial is testingPart 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic SyndromeWho this might be right forNephrotic Syndrome Aldeyra Therapeutics, Inc.
Not applicableActive Not RecruitingNCT02194582What this trial is testingGenetic Causes of FSGS, Nephrotic Syndrome, or Kidney FailureWho this might be right forFocal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more Beth Israel Deaconess Medical Center 2,050
Testing effectiveness (Phase 2)Study completedNCT03366337What this trial is testingTrial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIXWho this might be right forIgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more Biogen 103
Post-approval studies (Phase 4)Study completedNCT02585804What this trial is testingTreating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial EffectsWho this might be right forFocal Segmental Glomerulosclerosis University Health Network, Toronto 10
Post-approval studies (Phase 4)UnknownNCT04349683What this trial is testingEfficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to GlomerulonephritisWho this might be right forChronic Kidney Disease Stage 3BChronic Kidney Disease stage4Glomerulonephritis Jemincare 332
Post-approval studies (Phase 4)Looking for participantsNCT07030894What this trial is testingNefecon and Ambrisentan in IgA NephropathyWho this might be right forIgA NephropathyChronic Kidney DiseaseProteinuria The First Hospital of Jilin University 129
Testing effectiveness (Phase 2)UnknownNCT02682459What this trial is testingACE-inhibitors in Extracapillary GlomerulonephritisWho this might be right forExtracapillary Glomerulonephritis Monia Lorini 22
Post-approval studies (Phase 4)Looking for participantsNCT04263922What this trial is testingHuaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3Who this might be right forRenal Insufficiency, Chronic The First Affiliated Hospital of Dalian Medical University 466
Large-scale testing (Phase 3)Looking for participantsNCT06291376What this trial is testingStudy of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)Who this might be right forImmunoglobulin A NephropathyIgAN Alexion Pharmaceuticals, Inc. 510
Not applicableUnknownNCT04498962What this trial is testingThe Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket TrialWho this might be right forChronic Stable AnginaVascular DementiaIdiopathic Membranous Nephropathy Jingqing Hu 240
Testing effectiveness (Phase 2)Looking for participantsNCT07268638What this trial is testingPraliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)Who this might be right forFocal Segmental Glomerulosclerosis Akebia Therapeutics 60
Post-approval studies (Phase 4)Study completedNCT00319761What this trial is testingCalcitriol in the Treatment of Immunoglobulin A (IgA) NephropathyWho this might be right forIGA Nephropathy Chinese University of Hong Kong 10
Post-approval studies (Phase 4)Looking for participantsNCT06712407What this trial is testingEfficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA NephropathyWho this might be right forIgA Nephropathy Calliditas Therapeutics AB 60
Not applicableLooking for participantsNCT06682507What this trial is testingHigh Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)Who this might be right forLupus Nephritis (LN) First Affiliated Hospital, Sun Yat-Sen University 5,000
Not applicableUnknownNCT01126931What this trial is testingWormwood in Chronic Progressive Disorders With Reduced AppetiteWho this might be right forCancer University Hospital Freiburg 300
Testing effectiveness (Phase 2)Study completedNCT03373461What this trial is testingStudy of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by InflammationWho this might be right forIgA Nephropathy Novartis Pharmaceuticals 112
Large-scale testing (Phase 3)Active Not RecruitingNCT05852938What this trial is testingZigakibart in Adults With IgA NephropathyWho this might be right forIgA NephropathyImmunoglobulin A Nephropathy Novartis Pharmaceuticals 383
Post-approval studies (Phase 4)Study completedNCT01103778What this trial is testingPilot Study of Velcade® in IgA NephropathyWho this might be right forChronic Kidney DiseaseIgA Nephropathy The Rogosin Institute 11